| __timestamp | Corcept Therapeutics Incorporated | Takeda Pharmaceutical Company Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 26551000 | 1777824000000 |
| Thursday, January 1, 2015 | 50286000 | 1807378000000 |
| Friday, January 1, 2016 | 81321000 | 1732051000000 |
| Sunday, January 1, 2017 | 159201000 | 1770531000000 |
| Monday, January 1, 2018 | 251247000 | 2097224000000 |
| Tuesday, January 1, 2019 | 306486000 | 3291188000000 |
| Wednesday, January 1, 2020 | 353874000 | 3197812000000 |
| Friday, January 1, 2021 | 365978000 | 3569006000000 |
| Saturday, January 1, 2022 | 401858000 | 4027478000000 |
| Sunday, January 1, 2023 | 482375000 | 4263762000000 |
| Monday, January 1, 2024 | 4263762000000 |
Unleashing insights
In the ever-evolving pharmaceutical landscape, Takeda Pharmaceutical Company Limited and Corcept Therapeutics Incorporated stand as intriguing contrasts. Over the past decade, Takeda has consistently demonstrated its dominance, with annual revenues soaring from approximately $1.8 trillion in 2014 to an impressive $4.3 trillion by 2023. This represents a staggering growth of over 140%.
Meanwhile, Corcept Therapeutics, though smaller in scale, has shown remarkable growth. Starting with a modest $26 million in 2014, Corcept's revenue surged to nearly $482 million by 2023, marking an extraordinary increase of over 1,700%. This growth trajectory highlights Corcept's potential in the niche market of cortisol modulation.
While Takeda's revenue growth reflects its expansive global reach and diverse portfolio, Corcept's rise underscores the power of specialization and innovation in the pharmaceutical industry. The data for 2024 remains incomplete, leaving room for speculation on future trends.
Revenue Insights: Eli Lilly and Company and Corcept Therapeutics Incorporated Performance Compared
Comparing Revenue Performance: Sanofi or Takeda Pharmaceutical Company Limited?
Who Generates More Revenue? Takeda Pharmaceutical Company Limited or Alnylam Pharmaceuticals, Inc.
Comparing Revenue Performance: Takeda Pharmaceutical Company Limited or Sarepta Therapeutics, Inc.?
Who Generates More Revenue? Takeda Pharmaceutical Company Limited or ACADIA Pharmaceuticals Inc.
Annual Revenue Comparison: Takeda Pharmaceutical Company Limited vs Travere Therapeutics, Inc.
Annual Revenue Comparison: Takeda Pharmaceutical Company Limited vs BioCryst Pharmaceuticals, Inc.
Revenue Showdown: Viatris Inc. vs Corcept Therapeutics Incorporated
Revenue Insights: Catalent, Inc. and Corcept Therapeutics Incorporated Performance Compared
Comparing Revenue Performance: Corcept Therapeutics Incorporated or Geron Corporation?
Corcept Therapeutics Incorporated or Galapagos NV: Who Leads in Yearly Revenue?
Corcept Therapeutics Incorporated vs Celldex Therapeutics, Inc.: Examining Key Revenue Metrics